Loading…
← CockpitCompetitor Analysis › 002172.SZ Jiangsu Aoyang Health Industry Co. ltd. Class AOpen in the cockpit ↗

Jiangsu Aoyang Health Industry Co. ltd. Class A002172.SZCompetitor analysis, valuation and peers

China · CNY·Consumer Discretionary›Textiles
Momentum leader 99
Mkt cap
$637M
US dollars, full cap
Free float
93%
of shares outstanding
$/day
$137M
20-day average traded
Fwd P/E
n/m
no positive forecast
ROIC−WACC
+4.4 pp
WACC 6.2%
Hurdle
n/a
no reverse DCF
Close · CNYCN¥5.62
1D-7.1%
1W-4.9%
1M-0.7%
3M+71.3%
6M+47.5%
YTD+41.6%
1Y+31.3%
ATR %9.5%
52w lowhigh21.4% off high

What Jiangsu Aoyang Health Industry does

Employees: 2,012

Jiangsu Aoyang Health Industry at a glance

Size Jiangsu Aoyang Health Industry (002172.SZ) is a China Consumer Discretionary company (Textiles) with a market value of $637M, the 3275th largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥5.62 on 6 Nov 2026.

Performance Over six months the shares gained 47.5%, against -10.8% for the median peer and -16.4% for the China market (cap-weighted) — highest of 21 in its peer set.

Growth Revenue fell 9.2% over the last twelve months (peer median +5.0%); the operating margin is 3.7% (peer median 7.7%).

Valuation It trades at 2.8× enterprise value to sales against a peer median of 1.6× (5th most expensive of 21).

Capital Return on invested capital runs 4.4 points above its cost of capital (6.2% WACC).

Relative performance

10015011 May 202611 Aug 20266 Nov 2026002172.SZ 149Peer median 91
Six months, rebased to 100: Jiangsu Aoyang Health Industry against the median of its 20 peers (local-currency closes).

Jiangsu Aoyang Health Industry financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥1.70BCN¥1.81BCN¥2.01BCN¥2.16BCN¥2.01B
Revenue growth—-10%-7%+8%—
Gross profitCN¥233MCN¥223MCN¥243MCN¥256MCN¥239M
EBITDAn/aCN¥148MCN¥158MCN¥164MCN¥166M
Net incomeCN¥38.7MCN¥41.3MCN¥40.6MCN¥49.7M-CN¥15.4M
Free cash flow-CN¥56.5M-CN¥20.0M-CN¥28.2M-CN¥9.29M-CN¥227M
Capital expenditureCN¥16.0MCN¥32.6MCN¥28.6MCN¥63.6MCN¥193M
Total debtCN¥1.02BCN¥1.01BCN¥1.19BCN¥1.45BCN¥1.94B

Quarterly statements and history in the cockpit →

Jiangsu Aoyang Health Industry competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-40%-20%0%+20%+40%-20%-10%0%0024271440000936000726267800131214190007823008193104600626400800220160518930087732013002000850002674002172.SZ6-month return →1-month return →
Up and to the right = strong over both horizons. Jiangsu Aoyang Health Industry is the large dot.

Fundamentals: revenue growth against valuation

-20%0%+20%1×2×3×4×0024271440000936000726267800131214190007823008193104600626400800220130038460518930087732013002000850002674002172.SZRevenue growth (TTM) →EV / Sales →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Jiangsu Aoyang Health Industry is the large dot.

Jiangsu Aoyang Health Industry competitors and peer comparison

How Jiangsu Aoyang Health Industry compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Jiangsu Aoyang Health Industry against its 20 peers (data as of 6 Nov 2026)
Measure002172.SZPeer medianRank in peer set
1-month return-0.7%-5.5%7th highest of 21
6-month return+47.5%-10.8%highest of 21
Distance from 52-week high-21.4%-34.3%6th highest of 21
Revenue growth (TTM)-9.2%+5.0%3rd lowest of 21
Operating margin3.7%7.7%8th lowest of 21
EV / Sales2.8×1.6×5th most expensive of 21
ROIC minus cost of capital+4.4 pp-1.5 pp3rd highest of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginEV / SalesReq gDelivered g
Jiangsu Aoyang Health Industry 002172.SZChina$637M+48%-9%4%2.8×n/an/a
Zhejiang Unifull Industrial Fiber 002427.SZChina$636M-26%+3%3%2.0×n/an/a
Tainan Spinning 1440.TWTaiwan$639M+2%-21%-4%1.9×-0.5%-3.9%
Jiangsu Huaxicun 000936.SZChina$658M-31%+14%-5%1.2×n/an/a
Lu Thai Textile 000726.SZChina$658M-9%-3%8%0.6×-20.4%+4.5%
Texhong International 2678.HKHong Kong$587M-32%+6%8%0.3×-20.5%+2.3%
Hangzhou Fuen 001312.SZChina$582M-29%-5%14%1.8×-3.6%-0.8%
Shinkong Textile 1419.TWTaiwan$574M0%+19%9%3.3×10.8%+17.1%
Guangdong Highsun Meida New Materials 000782.SZChina$728M-4%0%-5%2.4×n/an/a
Jiangsu Jujie Microfiber Technology 300819.SZChina$734M-42%+5%9%8.4×n/an/a
Fujibo 3104.TJapan$551M-34%+14%18%1.5×1.3%+4.5%
Shanghai Shenda 600626.SSChina$745M-4%-2%1%0.6×-1.0%-0.1%
Sumitomo Seika Chemicals 4008.TJapan$545M+12%+5%10%0.6×-5.2%+7.5%
Jiangsu Jiuding New Material 002201.SZChina$760M-42%+6%9%3.0×22.1%+1.4%
Beijing Sanlian Hope Shin-Gosen Technical Service 300384.SZChina$533M-21%-36%15%3.9×6.5%-1.3%
Fuchun Dye and Weave 605189.SSChina$523M-13%+29%4%1.3×6.5%+17.6%
AnHui Jinchun Nonwoven 300877.SZChina$522M-3%+28%3%2.4×18.0%0.0%
Japan Wool Textile 3201.TJapan$792M+14%0%11%0.9×-8.6%+2.6%
Gunze 3002.TJapan$797M+17%-4%5%1.1×10.5%+1.1%
Anhui Huamao Textile 000850.SZChina$504M-22%+8%3%1.1×n/an/a
Xingye Leather Technology 002674.SZChina$807M+35%+7%8%1.9×14.3%+15.4%

Questions

Which companies are Jiangsu Aoyang Health Industry's closest peers?
The cockpit's peer set: Zhejiang Unifull Industrial Fiber (002427.SZ), Tainan Spinning (1440.TW), Jiangsu Huaxicun (000936.SZ), Lu Thai Textile (000726.SZ), Texhong International (2678.HK), Hangzhou Fuen (001312.SZ), Shinkong Textile (1419.TW), Guangdong Highsun Meida New Materials (000782.SZ).
Is Jiangsu Aoyang Health Industry expensive compared with its peers?
On ev / sales it trades at 2.8× against a peer median of 1.6×, 5th most expensive of 21 in its peer set.
How has Jiangsu Aoyang Health Industry stock performed?
Over six months to 6 Nov 2026 the shares returned +47.5% against -10.8% for the median peer; over one year +31.3%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.